Abstract
In vivo fluorescence lifetime (FLT) imaging is an emerging and promising modality with the potential to provide additional biological information compared to fluorescence intensity (FI) imaging. Until now, nearly all studies evaluating the benefits of FLT imaging in vivo have been conducted using cyanine dyes. While these fluorophores are highly successful for conventional in vivo fluorescence imaging due to their unmatched brightness in the NIR-I region (700-900 nm), they might be suboptimal for FLT imaging. Indeed, NIR-I cyanines are characterized by short singlet excited-state lifetime (generally below 1 ns) making it challenging to differentiate them from tissue autofluorescence. Therefore, there is a pressing need for biocompatible fluorophores with longer FLTs. Herein, we report a novel bioconjugatable water-soluble NIR-emissive aza-BODIPY dye with extended FLT values in physiological conditions, compared to cyanine dyes (increase of 100% compared to IRDye® 800CW). The suitability of aza-BODIPY for FLT imaging when conjugated to an antibody was assessed to enhance this technology. Beyond rational design and synthesis of a long-wavelength fluorophore with attractive features for in vivo FLT imaging, this study also highlights for the first time the impact of the conjugation method on the FLT characteristics of the resulting fluorescent antibody conjugates.
Supplementary materials
Title
Supporting Information
Description
All experimental details related to (1) synthesis and spectroscopic/photophysical characterizations of fluorophores, (2) preparation and bioanalytical characterization of fluorescent antibody conjugates, and (3) FLT imaging experiments.
Actions